8月5日，Hinge Health盘中上涨5.03%，报81.555美元/股，成交额8716.58万美元。消息面上，公司于8月4日盘后发布Q2财报，市场此前一致预期本季度营收约2.01亿美元（同比增长60.38%），调整后每股收益0.59美元（同比增长582.69%）。
近期多项利好持续催化：摩根士丹利将目标价从72美元大幅上调至108美元，维持"增持"评级；一项临床研究显示其跌倒预防项目使65岁以上人群跌倒次数减少37%、急诊就诊几率降低57%；公司此前已将全年营收指引上调至8.18亿至8.24亿美元，高于分析师预期的8.016亿美元。Hinge Health是一家AI驱动的数字肌肉骨骼护理平台，通过可穿戴设备和专业临床团队提供从急性损伤到术后康复的全流程服务。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.